9,10 These and other observations motivated the development of PHGDH inhibitors as potential cancer therapies.11 However, in most cases uptake of exogenous serine appears to be sufficient to offset inhibition of the synthesis pathway,12,13 thus limiting the efficacy of PHGDH inhibitors as potential therapeutic agents. This evidence concerns the gene PHGDH and cancer.